Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH
Authors:
Open Access
- 17 April 2025
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (5) , 102085
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (APP1162511)
- National Health and Medical Research Council (APP1143224)
- National Health and Medical Research Council (APP2009642)
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
- Melbourne Research, University of Melbourne
This publication has 91 references indexed in Scilit:
- Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in miceAnimal Models and Experimental Medicine, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐upHepatology, 2014
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective studyHepatology, 2014
- Prothrombotic factors and nonalcoholic fatty liver disease: An additional link to cardiovascular risk?Hepatology, 2013
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §ΔHepatology, 2010
- Serum Proteomics and Biomarker Discovery Across the Spectrum of Nonalcoholic Fatty Liver DiseaseHepatology, 2009
- Comprehensive and quantitative proteome profiling of the mouse liver and plasmaHepatology, 2008
- A Genomic and Proteomic Study of the Spectrum of Nonalcoholic Fatty Liver Disease *Hepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005